MCT-1 stimulated IL-6/Stat3 signaling (Fig. 2e), suggesting that MCT-1 may also stimulate the NO/NOTCH pathway to mediate breast cancer metastasis and recurrence. Here, IL6 is linked to breast carcinoma.